GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $409,000 | +87.6% | 6,016 | -4.8% | 0.23% | +260.0% |
| Q1 2022 | $218,000 | -28.3% | 6,321 | -39.3% | 0.06% | -19.8% |
| Q4 2021 | $304,000 | -5.9% | 10,418 | -17.9% | 0.08% | +14.1% |
| Q3 2021 | $323,000 | +47.5% | 12,696 | +108.6% | 0.07% | +69.0% |
| Q2 2021 | $219,000 | -13.1% | 6,086 | -1.6% | 0.04% | -14.3% |
| Q1 2021 | $252,000 | -7.4% | 6,188 | -1.6% | 0.05% | 0.0% |
| Q4 2020 | $272,000 | -13.4% | 6,288 | +10.4% | 0.05% | -23.4% |
| Q3 2020 | $314,000 | -8.5% | 5,695 | +4.9% | 0.06% | -14.7% |
| Q2 2020 | $343,000 | +23.4% | 5,430 | -0.1% | 0.08% | +8.7% |
| Q1 2020 | $278,000 | +16.3% | 5,435 | +80.8% | 0.07% | +43.8% |
| Q4 2019 | $239,000 | – | 3,006 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |